EXAMPLE 2- Preparation of 2-(2-(4-(2-furoyl)piperazinyl)ethyl)-2,4-dihydro-7-methoxy-4,4-dimethylchromeno[4,3-c]pyrazole.
The desired compound was prepared according to the procedure described for Example 1 using 2-(2-bromoethyl)-7-methoxy-4,4-dimethyl-1,4-dihydrochromeno[4,3-c]pyrazole (20 mg, 0.06 mmol) and 1-(2-furoyl)piperazine (11 mg, 0.06 mmol). Yellow oil (6 mg, 24%);